Join Our Volunteer Mailing List | Parexel Clinical Trials

First Name*

Last Name*

Email Address*

Home Phone*

Mobile Phone*

Country*

If other, please describe briefly here:

Privacy Statement: By clicking on the “I agree to the above conditions” button you consent to Parexel International processing your personal information in accordance with this Data Protection Consent for Online Survey Participants. Data Protection Consent for Online Survey Participants I understand that the Clinical Pharmacology Research Unit of Parexel International Ltd. Level 7, Northwick Park Hospital, Watford Road, Harrow, HA1 3UJ (in the following “Parexel International”) is the controller of the personal data I provide herewith. Parexel International shall process my personal data to respond to my requests for information, recruiting volunteers, administering the recruitment process and analysing recruitment methods and results. My personal data will be retained as long as necessary for the purposes it has been collected for, but not longer than 3 years without my being contacted again. Whilst completing the registration questionnaire, I understand that if I quit at any time prior to submitting the form, no record of the information I have provided up to that point will be saved. Data that I supply will be added to a volunteer database maintained by Parexel International in the UK. All data stored in this volunteer database will be used in accordance with this statement, and any changes to the way my personal data is handled will only be made with my written consent (for example if I take part in a study my data may be shared with one of Parexel International´s clients sponsoring the trial). Parexel International reserves the right to disclose all information collected to the extent required by law. Parexel International may contact me from time to time by phone, e-mail or SMS about forthcoming trials that I may be interested in. If I no longer wish to remain in the Parexel International volunteers’ database, I can opt-out at any time by sending an e-mail to drugtrial@parexel.com. I should state my name and date of birth on all communications and a member of Parexel International´s team will ‘deactivate’ my account. I understand that I can request access to and/or correction of my personal data by contacting Parexel International in writing at the address mentioned above. By accepting the present form, I consent that Parexel International may also share my contact information only with agents, contractors or partners of the mother company of Parexel International, including to entities located in countries that, under the EU principles, do not offer an adequate level of protection of personal data, in connection with services that these individuals or entities perform for, or with, Parexel International. Such third parties are restricted from using this data in any way other than providing services for or on behalf of Parexel International, the mother company of Parexel International or its affiliates. Parexel International may, for example, provide my contact information to third parties contracted by Parexel International to handle group mailings. The supply of my personal data to Parexel International is voluntary. I acknowledge that if I do not wish Parexel International to collect, process or disclose such data in accordance with this statement, I will not attempt to provide Parexel International with such data.

I agree to the above conditions

Communications Preference*

Stay connected with PAREXEL!

I would like to receive marketing communications from PAREXEL and consent to the processing of the personal data that I provide in accordance with and as described in the Privacy Policy.

Accept Decline

Comments

By clicking on the “I agree to the above conditions” button you consent to Parexel International processing your personal information in accordance with this Data Protection Consent for recipient of the Study Alert Mailing List.

Data Protection Consent for Recipients of Study Alert Mailing List

You understand that the Clinical Pharmacology Research Unit of Parexel International Ltd. Level 7, Northwick Park Hospital, Watford Road, Harrow, HA1 3UJ (in the following “Parexel International”) is the controller of the personal data I provide herewith. Parexel International shall process your personal data for the purpose to add you to the London clinical unit Study Alert Mailing List.

Your personal data will be retained as long as necessary for the purposes it has been collected for, but not longer than 3 years without you being contacted again. Parexel International reserves the right to disclose all information collected to the extent required by law.

Parexel International USA, the ultimate parent company of Parexel International Ltd., implemented a communication system operated by the third party vendor Salesforce located in the USA which will allow you to receive notifications about clinical trials and activities at our London clinical unit via e-mail. Note: Both the vendor, Salesforce, as well as Parexel International USA, operate under the EU-US Privacy Shield Framework regarding the collection, use, and retention of personal data transferred from EEA member countries to the U.S. Please visit the following web pages to learn more about Salesforce's and Parexel's self-certification to the EU-US Privacy Shield Framework:

•Parexel ‘s EU-US Privacy Shield Notice https://www.parexel.com/company/privacy-shield-notice

•Salesforce's EU Data Transfer Mechanisms FAQ https://www.salesforce.com/company/privacy/.

In the future, Parexel may opt to work with other third party vendors located in the USA or in other countries, to implement the communication system. Parexel will ensure that in such case the transfer of your personal data to such vendor will be covered by the EU-US Privacy Shield Framework or another transfer mechanism approved by the EU. Parexel will notify you in case of use of any other third party vendor.

Whilst completing the registration questionnaire, you understand that if you quit at any time prior to submitting the form, no record of the information you have provided up to that point will be saved.

If you no longer wish to receive e-mails from the London clinical unit Study Alert Mailing List, you can opt-out at any time by sending an e-mail to drugtrial@parexel.com. You should state your name and email address on such communications and a member of Parexel International's team will ‘deactivate’ your Study Alert Mailing List account.

You understand that you can request access to and/or correction of your personal data by contacting Parexel International in writing at the address mentioned above.

Thank you for your interest.

You will now be notified of future clinical trials at our office. Please check your e-mail for a confirmation message. Click here to return to our list of available studies.

Healthy Volunteer
Allergies
Alzheimer's Disease
Arthritis
Asthma
Cancer
Cholesterol
COPD
Depression
Dermatology
Diabetes
Heart
Hepatitis
HIV
Multiple Sclerosis
Obesity/Weight Management
Osteoporosis
Parkinson's Disease
Postmenopausal
Psoriasis
Schizophrenia
Smoking (No)
Smoking (Yes)